TY - JOUR
T1 - Treatment of stage IV‐S neuroblastoma
T2 - A study of 34 cases treated between 1982 and 1987
AU - Suarez, Alcira
AU - Hartmann, Olivier
AU - Vassal, Gilles
AU - Giron, Alain
AU - Habrand, Jean Louis
AU - Valteau, Dominique
AU - Brugieres, Laurence
AU - Kalifa, Chantal
AU - Lemerle, Jean
PY - 1991/1/1
Y1 - 1991/1/1
N2 - Between January 1982 and December 1987, of 283 children with neuroblastoma treated in the Pediatric Department of Institut Gustave Roussy, 34 were stage IV‐S. Two groups were distinguished according to the initial clinical presentation: 16/34 patients had life‐threatening symptoms and needed immediate treatment, and 18/34 had no life‐threatening symptoms. Hepatic irradiation was used in 12/16 patients of the first group with respiratory distress. Chemotherapy was used in three patients. Of these 16 patients, three patients died of progressive disease (one patient died of a reason not related to the tumor). Twelve are alive in first complete remission and one in second complete remission. Of the 18, patients of the second group, eight had spontaneous complete remission, and one of them relapsed thereafter and died despite treatment. Ten patients needed treatment, radiotherapy, and/or chemotherapy depending on the site of disease progression. Two of them died of the disease. The overall disease‐free survival for these 34 patients is 75% at 90 months postdiagnosis. Using this therapeutic strategy, it was possible to avoid any treatment of metastases in 25% of the patients.
AB - Between January 1982 and December 1987, of 283 children with neuroblastoma treated in the Pediatric Department of Institut Gustave Roussy, 34 were stage IV‐S. Two groups were distinguished according to the initial clinical presentation: 16/34 patients had life‐threatening symptoms and needed immediate treatment, and 18/34 had no life‐threatening symptoms. Hepatic irradiation was used in 12/16 patients of the first group with respiratory distress. Chemotherapy was used in three patients. Of these 16 patients, three patients died of progressive disease (one patient died of a reason not related to the tumor). Twelve are alive in first complete remission and one in second complete remission. Of the 18, patients of the second group, eight had spontaneous complete remission, and one of them relapsed thereafter and died despite treatment. Ten patients needed treatment, radiotherapy, and/or chemotherapy depending on the site of disease progression. Two of them died of the disease. The overall disease‐free survival for these 34 patients is 75% at 90 months postdiagnosis. Using this therapeutic strategy, it was possible to avoid any treatment of metastases in 25% of the patients.
KW - chemotherapy
KW - infants
KW - neonates
KW - radiotherapy
UR - http://www.scopus.com/inward/record.url?scp=0026344273&partnerID=8YFLogxK
U2 - 10.1002/mpo.2950190605
DO - 10.1002/mpo.2950190605
M3 - Article
C2 - 1961134
AN - SCOPUS:0026344273
SN - 0098-1532
VL - 19
SP - 473
EP - 477
JO - Medical and Pediatric Oncology
JF - Medical and Pediatric Oncology
IS - 6
ER -